Please assess the completion status of the following clinical trial:

Trial Title: Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects meeting the pre-defined GFR (glomerular filtration rate) criteria (estimated by the Cockcroft and Gault formula) for any of the renal function groups~* Body Mass Index (BMI) maximum 40 kg/m\^2~Exclusion Criteria:~* Known or suspected allergy to trial product(s) or related products~* Renal transplanted patients~* Haemodialysis patients~* Cardiac problems~* Uncontrolled treated/untreated hypertension~* History of alcoholism or drug abuse during the last 12 months~* Smoking of more than 10 cigarettes per day, or the equivalent for other tobacco products~* Habitual excessive consumption of methylxanthine-containing beverages and foods (coffee, tea, soft drinks such as cola, chocolate) as judged by the investigator~* Excessive consumption of food deviating from a normal diet as judged by the Investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Normal renal function (Type: EXPERIMENTAL): None
- Mild renal impairment (Type: EXPERIMENTAL): None
- Moderate renal impairment (Type: EXPERIMENTAL): None
- Severe renal impairment (Type: EXPERIMENTAL): None
- End-stage renal disease (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).